@article{1bb6aa390ef542a29c099d7ed516068e,
title = "Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids",
keywords = "antibody formation, immunotherapy, oncolytic virotherapy, GAMMA-RS, T-CELLS, ANTIBODY, CANCER, NEUTROPHILS, RECEPTOR, EFFICACY, REPLICATION, BLOCKADE, THERAPY, 317 Pharmacy, 3122 Cancers, 1182 Biochemistry, cell and molecular biology",
author = "Firas Hamdan and Erkko Yl{\"o}sm{\"a}ki and Jacopo Chiaro and Yvonne Giannoula and Maeve Long and Manlio Fusciello and Sara Feola and Beatriz Martins and Michaela Feodoroff and Gabriella Antignani and Salvatore Russo and Otto Kari and Moon Lee and Petrus J{\"a}rvinen and Harry Nisen and Anna Kreutzman and Jeanette Leusen and Satu Mustjoki and McWilliams, {Thomas G.} and Mikaela Gr{\"o}nholm and Vincenzo Cerullo",
year = "2021",
doi = "10.1136/jitc-2021-003000",
language = "English",
volume = "9",
journal = "Journal for Immunotherapy of Cancer",
issn = "2051-1426",
publisher = "BioMed Central",
number = "8",
}